Cost-effectiveness of interventions to reduce the thrombolytic delay for acute myocardial infarction

International Journal of Technology Assessment in Health Care

Volumn 20, Issue 3, 2004, Pages 368-374

  Kildemoes, Helle Wallach ^a   Kristiansen, Ivar Sønbø ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Delay; Economics; Myocardial infarction; Thrombolytic therapy

Indexed keywords

COST EFFECTIVENESS; DIAGNOSIS; HEALTH CARE; PATIENT TREATMENT;

ACUTE MAYOCARDIAL INFARCTION (AMI); THROMBOLYSIS;

CARDIOLOGY;

STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG COST; EARLY DIAGNOSIS; FIBRINOLYTIC THERAPY; HUMAN; LIFE EXPECTANCY; MORTALITY; SWEDEN; TELECOMMUNICATION;

EID: 4043162619     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0266462304001205     Document Type: Article

References (32)

1. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Lancet. 1986;1:397-402.
2. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet. 1994;343:311-322.
3. [Befolkningens bevœgelser 1997-Vital statistics 1997]. Copenhagen: Statistics Denmark; 1999.
4. Andersen HR, Nielsen TT, Vesterlund T, et al. Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: Rationale and design of the Danish trial in acute myocardial infarction-2. Am Heart J. 2003;146:234-241.
5. Blohm M, Herlitz J, Schroder U, et al. Reaction to a media campaign focusing on delay in acute myocardial infarction. Heart Lung. 1991;20:661-666.
6. Blohm MB. Delay time until delivery of treatment in suspected acute myocardial infarction. An intervention study with particular emphasis on patient delay. Göteborg: 1997.
7. Blohm MB, Hartford M, Karlson BW, Luepker RV, Herlitz J. An evaluation of the results of media and educational campaigns designed to shorten the time taken by patients with acute myocardial infarction to decide to go to hospital. Heart. 1996;76:430-434.
8. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour. Lancet. 1996;348:771-775.
9. Brønnum-Hansen H, Jørgensen T, et al. Survival and cause of death after myocardial infarction. The Danish MONICA study. J Clin Epidemiol. 2001;54:1244-1250.
10. Drummond MF, O'Brian BJ, Stoddard GL, Torrance GW. Methods for economic evaluation of health care programmes. 1999. Oxford, New York, Toronto: Oxford University Press.
11. Gaspoz JM, Unger PF, Urban P, et al. Impact of a public campaign on pre-hospital delay in patients reporting chest pain. Heart. 1996;76:150-155.
12. Herlitz J, Blohm M, Hartford M, et al. Follow-up of a 1-year media campaign on delay times and ambulance use in suspected acute myocardial infarction. Eur Heart J. 1992;13:171-177.
13. Herlitz J, Hartford M, Blohm M, et al. Effect of a media campaign on delay times and ambulance use in suspected acute myocardial infarction. Am J Cardiol. 1989;64:90-93.
14. Herlitz J, Hartford M, Karlson BV, et al. Effect of a media campaign to reduce delay times for acute myocardial infarction on the burden of chest pain patients in the emergency department. Cardiology. 1991;79:127-134.
15. Herlitz J, Hartford M, Karlson BW, et al. One-year mortality after acute myocardial infarction prior to and after the implementation of a widespread use of thrombolysis and aspirin. Experiences from the community of Goteborg, Sweden. Cardiology. 1998;89:216-221.
16. Ho MT, Eisenberg MS, Litwin PE, Schaeffer SM, Damon SK. Delay between onset of chest pain and seeking medical care: The effect of public education. Ann Emerg Med. 1989;18:727-731.
17. Holmberg M, Holmberg S, Herlitz J. Incidence, duration and survival of ventricular fibrillation in out-of-hospital cardiac arrest patients in Sweden. Resuscitation. 2000;44:7-17.
18. Holmberg M, Holmberg S, Herlitz J, Gardelov B. Survival after cardiac arrest outside hospital in Sweden. Swedish Cardiac Arrest Registry. Resuscitation. 1998;36:29-36.
19. Karagounis L, Ipsen SK, Jessop MR, et al. Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction. Am J Cardiol. 1990;66:786-791.
20. Kereiakes DJ, Gibler WB, Martin LH, Pieper KS, Anderson LC. Relative importance of emergency medical system transport and the prehospital electrocardiogram on reducing hospital time delay to therapy for acute myocardial infarction: A preliminary report from the Cincinnati Heart Project. Am Heart J. 1992;123(pt 1):835-840.
21. Luepker RV, Raczynski JM, Osganian S, et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial. JAMA. 2000;284:60-67.
22. Madsen JK, Pedersen F, Nielsen H, Jensen GV, Hansen JF. Improvement in long-term prognosis of elderly patients with acute myocardial infarction after the introduction of intravenous thrombolytic therapy. Scand Cardiovasc J. 1998;32:365-370.
23. Maggioni AP, Maseri A, Fresco C, et al. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). N Engl J Med. 1993;329:1442-1448.
24. Mark DB, Hlatky MA, Califf RM, et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med. 1995;332:1418-1424.
25. Moon JCC, Kalra PR, Coats AJS. DANAMI-2: Is primary angioplasty superior to thrombolysis in acute MI when the patient has to be transferred to an invasive centre? Cardiology. 2002;85:199-201.
26. Moses HW, Engelking N, Taylor GJ, et al. Effect of a two-year public education campaign on reducing response time of patients with symptoms of acute myocardial infarction. Am J Cardiol. 1991;68:249-251.
27. Nielsen TT, Andersen HR. [Primary percutaneous coronary intervention of ST elevation myocardial infarction, the DANAMI 2 study. The Danish Society of Cardiology]. Ugeskr Laeger. 2003;165:1227.
28. Ottesen MM, Kober L, Jorgensen S, Torp-Pedersen C. Determinants of delay between symptoms and hospital admission in 5978 patients with acute myocardial infarction. The TRACE Study Group. Trandolapril Cardiac Evaluation. Eur Heart J. 1996;17:429-437.
29. Parmley WW. Cost-effectiveness of reperfusion strategies. Am Heart J. 1999;138(pt 2):S142-S152.
30. Rasmussen CH. [Out-of-hospital cardiac arrest]. Ugeskr Laeger. 2000;162:3887.
31. Rustige JM, Burczyk U, Schiele R, Werner A. Media campaign on delay times in suspected myocardial infarction. The Ludwigshafen project. Abstract. Eur Heart J. 1999;11(Suppl):17.
32. Videbæk J, Madsen M. Heart statistics. Copenhagen: Danish Heart Foundation and Danish Institute of Clinical Epidemiology; 1999.